| Patents for C07D 261 - Heterocyclic compounds containing 1,2-oxazole or hydrogenated 1,2-oxazole rings (11,459) |
|---|
| 02/08/2006 | EP1622870A2 Glutaminyl based dp iv-inhibitors |
| 02/08/2006 | EP0812318B1 4-aminotetrahydrobenzisoxazole or -isothiazole compounds |
| 02/08/2006 | CN1732161A 1,3-diamino-2-hydroxypropane pro-drug derivatives |
| 02/08/2006 | CN1732152A Phenethanolamine derivative for the treatment of respiratory diseases |
| 02/08/2006 | CN1732146A Cycloalkyl inhibitors of potassium channel function |
| 02/08/2006 | CN1240690C Preparation method and use of sulfalene oxazole derivative |
| 02/08/2006 | CN1240677C Monofluoroalkyl derivatives |
| 02/07/2006 | US6995272 Crystal form of N-(4-trifluoromethylphenyl)-5-methylisoxazole-4-carboxamide |
| 02/07/2006 | US6995271 An intermediate to an antidiabetic compound, by reacting methyl (2-hydrocarbyl-5-methyloxazol-2-yl)acetate with sodium borohydride (NaBH4) using tetrahydrofuran as a solvent and methanol as activator; acetate becomes a 2-hydroxy ethyl group |
| 02/07/2006 | US6995181 hyterocyclylaminomethyl- or aminocarbonyl-substituted 9,10-ethanoanthracenes or their aza derivatives; treating obesity, diabetes, inflammatory and immune disorders |
| 02/07/2006 | US6995142 Antipicornaviral compounds and compositions, their pharmaceutical uses, and materials for their synthesis |
| 02/02/2006 | WO2006011466A1 5-substituted-2-phenylamino-benzamide as mek inhibitor |
| 02/02/2006 | US20060025460 isoxazolidine compounds, that B-cell lymphoma (BCL) proteins and block Bcl antiapoptotic function in cancer cells and tumor tissue; anticarcinogenic agents |
| 02/02/2006 | US20060025416 Substituted aryl acylthioureas and related compounds; inhibitors of viral replication |
| 02/02/2006 | US20060025415 Compositions useful as inhibitors of voltage-gated sodium channels |
| 02/01/2006 | EP1620412A2 Heterocyclic compounds and hydro isomers thereof |
| 02/01/2006 | EP1620091A2 Inhibitors of glutaminyl cyclase |
| 02/01/2006 | EP1620086A1 Compounds that modulate ppar activity and methods of preparation |
| 02/01/2006 | EP1476419B1 N-biphenylmethyl aminocycloalkanecarboxamide derivatives |
| 02/01/2006 | CN1239478C 3,4-dibidro-1H-anphthalene derivatives used as high selectivity inhibitor of cyclooxygenase-2 |
| 01/31/2006 | US6992081 Such as 4-((6-(3,5-difluoro-phenyl)-5-(S)-(3-dipropylcarb-amoyl-benzoyl-amino)-2-(R)-ethyl-4-(S)-hydroxy-hexanoylamino)-methyl)-cyclohexanecarboxylic acid for inhibiting secretase activity and cleavage of amyloid precursor protein |
| 01/26/2006 | WO2006009869A1 Coumpounds and methods for inhibiting the interaction of bcl proteins with binding partners |
| 01/26/2006 | US20060020004 Isoxazolidine compounds for treatment of bacterial infections |
| 01/26/2006 | CA2574217A1 Diamine derivative, process of preparation thereof, and fungicide comprising diamine derivative as an active ingredient |
| 01/26/2006 | CA2570780A1 Compounds and methods for inhibiting the interaction of bcl proteins with binding partners |
| 01/25/2006 | EP1224189B1 Condensed dihydroquinolinone derivatives for inhibiting mrp1 |
| 01/19/2006 | US20060014836 e.g. 1-(Benzofuran-2-carbonyl-3-(3-phenoxy-phenyl)-thiourea;viricides; hepatitis virus |
| 01/19/2006 | US20060014830 2-amino-2-oxoethyl 1-(4'-fluoro-1,1'-biphenyl-4-yl)cyclopropylmethylcarbamate and 2-(methylamino)-2-oxoethyl 1-(4'-fluoro-1,1'-biphenyl-4-yl)cyclopropylmethylcarbamate; fatty acid amide (FAAH) hyrdrolase inhibitors; analgesics; neuropathic pain;psychological disorders; anticarcinogenic agents; AIDS |
| 01/19/2006 | US20060014814 reacting 3-bromomethyl-1,2-benzisoxazole and ammonium sulfite in an alcohol and water mixture, to obtain a nonhygroscopic and anhydrous 1,2-benzisoxazole-3-methanesulfonic acid ammonium salt; converting a 1,2-benzisoxazole-3-methanesulfonic acid ester to 1,2-benzisoxazole-3-methanesulfonamide |
| 01/19/2006 | US20060014813 Pharmaceutical compounds that regenerate in vivo |
| 01/19/2006 | US20060014806 Dihalo-allyloxy-phenol derivatives having pesticidal activity |
| 01/19/2006 | US20060014752 Heterocyclic anti-epileptogenic agents and methods of use thereof |
| 01/19/2006 | US20060014743 Methods of preventing bacterial infections with florfenicol-type antibiotics |
| 01/18/2006 | EP1615892A2 Benzamide 2-hydroxy-3-diaminoalkanes |
| 01/18/2006 | EP1615636A1 Bicyclic compounds as nr2b receptor antagonists |
| 01/18/2006 | CN1721411A Benzimidazole derivatives as modulators IgE |
| 01/18/2006 | CN1237051C Fungicidal heterocyclic aromatic amides and their compositions, methods of use and preparation |
| 01/12/2006 | WO2005094810A3 Novel pharmaceutical compositions |
| 01/12/2006 | US20060009644 Novel crystalline forms of sodium 1,2-benzisoxazole-3-methanesulfonate, processes of preparing same and use thereof in the synthesis of zonisamide |
| 01/12/2006 | US20060009528 Cannabinoid receptor ligands |
| 01/12/2006 | US20060009446 New compounds |
| 01/12/2006 | CA2572872A1 Tissue factor production inhibitor |
| 01/11/2006 | EP1614680A2 Process for preparing 2-iminopyrrolidine derivatives |
| 01/11/2006 | EP1614678A2 Sulfur substituted sulfonylaminocarboxylic acid N-heteroarylamides, their preparation, their use and pharmaceutical preparations comprising them |
| 01/11/2006 | EP1614676A1 Compound inhibiting in vivo phosphorus transport and medicine containing the same |
| 01/11/2006 | EP1613608A1 Phospholipase inhibitors |
| 01/11/2006 | EP1379136A4 Preparation of ketones from aldehydes |
| 01/11/2006 | CN1720239A Process for the preparation of 1,2-dichloroethane free crystals of zonisamide and high pure crystals of zonisamide |
| 01/11/2006 | CN1235887C Preparation method of xazolyl alcohol derivatives |
| 01/11/2006 | CN1235870C Novel use of phenyl hetero alkylamine derivatives |
| 01/10/2006 | US6984650 Comprises phosphorescence and fluorescence resonance energy transfer; binding chenodeoxycholic acid to farnesoid X receptors; for regulating cholesterol absorption; for treatment of obesity |
| 01/10/2006 | US6984648 TNF (tumor necrosis factor); for treating conditions such as rheumatoid and osteoarthritis, corneal, epidermal or gastric ulceration; tumor metastasis or invasion; periodontal disease and bone disease |
| 01/10/2006 | CA2383332C Benzisoxazolyl-, pyridoisoxazolyl- and benzthienyl-phenoxy derivatives useful as d4 antagonists |
| 01/05/2006 | WO2005094329A8 Compouns, compositions, processes of making, and methods of use related to inhibiting macrophage migration inhibitory factor |
| 01/05/2006 | US20060004066 Method for treating ADAMTS-5-associated disease |
| 01/05/2006 | US20060004059 Substituted heterocycles for the treatment of diabetes and other diseases |
| 01/04/2006 | EP1611112A1 Isoxazole compounds as inhibitors of heat shock proteins |
| 01/04/2006 | EP1611088A2 Hydroxamates as therapeutic agents |
| 01/04/2006 | EP1363873A4 Peptide deformylase inhibitors |
| 01/04/2006 | EP1102755B1 Substituted isoxazole derivatives as estrogen receptor modulators |
| 01/03/2006 | US6982336 1,2-dioxetane derivatives, luminescent reagents, luminescence methods and measuring methods |
| 12/29/2005 | WO2005123701A1 Method for the preparation of diarylisoxazole sulfonamide compounds and intermediates |
| 12/29/2005 | WO2005123667A1 Substituted bicyclooctenes and their use as herbicides |
| 12/29/2005 | WO2005123073A1 Marine compounds with calcium channel blocking properties for the treatment of cognitive or neurodegenerative diseases |
| 12/29/2005 | US20050288516 Use of a device or devices, such as a convergent divergent funnel mixer, to optimize the available reaction volume, the raw material feed ratios and the weight hourly space velocity in a tube reactor |
| 12/29/2005 | US20050288324 Aromatic sulfonamides as peroxynitrite-rearrangement catalysts |
| 12/29/2005 | US20050288275 New compounds |
| 12/29/2005 | US20050288186 1-(4-{3-[2,6-Dichloro-4-(3,3-dichloro-allyloxy)-phenoxy]-propoxy}-phenyl)-1H-pyrrole, for example; protecting soybean plants against pests such as caterpillars |
| 12/28/2005 | EP1609783A1 Marine compounds with calcium channel blocking properties for Alzheimer's disease treatment |
| 12/28/2005 | CN1714070A Vitamin d receptor modulators |
| 12/28/2005 | CN1233634C Chemical synthesis method of 3-phenyl-5-methylisoxazole-4-formyl chloride |
| 12/27/2005 | US6979566 Method of treatment of viral infection including HIV using water soluble fullerenes—III |
| 12/22/2005 | WO2005120515A2 Novel sulfonamides as inhibitors of histone deacetylase for the treatment of disease |
| 12/22/2005 | WO2005120499A1 Form a of valdecoxib suitable for pharmaceutical formulations |
| 12/22/2005 | US20050282908 Substituted aminopropoxyaryl derivatives useful as agonists for LXR |
| 12/22/2005 | US20050282881 Glucocorticoid mimetics, methods of making them, pharmaceutical compositions, and uses thereof |
| 12/22/2005 | US20050282819 Heterocyclic substituted indane derivatives and related compounds for the treatment of schizophrenia |
| 12/22/2005 | US20050282787 Synthesis of tetracyclines and analogues thereof |
| 12/22/2005 | CA2567835A1 Novel sulfonamides as inhibitors of histone deacetylase for the treatment of disease |
| 12/21/2005 | EP1606283A2 P38 inhibitors and methods of use thereof |
| 12/21/2005 | EP1362039B1 Heterocyclic substituted carbonyl derivatives and their use as dopamine d3 receptor ligands |
| 12/21/2005 | CN1232511C Process for preparing oxazolyl acetate derivative and its salts |
| 12/20/2005 | US6977258 Antiinflammatory agents; cardiotonic agents; rheumatic diseases |
| 12/15/2005 | WO2005119315A2 Non-linear optically active molecules, their synthesis, and use |
| 12/15/2005 | WO2005118532A1 Improved method for preparing 3-hydroxy-4-hydroxymethyl-pyrrolidine compounds |
| 12/15/2005 | US20050277678 5-(4-Fluorophenyl)-1-(4-methylsulfoximinylphenyl)-3-trifluoromethyl-1H-pyrazole; prostaglandin and cyclooxygenase inhibitor; antiinflammatory, analgesic, and antipyretic agent |
| 12/15/2005 | CA2568836A1 Improved method for preparing 3-hydroxy-4-hydroxymethyl-pyrrolidine compounds |
| 12/15/2005 | CA2565705A1 Non-linear optically active molecules, their synthesis, and use |
| 12/14/2005 | EP1603858A2 Kcnq channel modulating compounds and their pharmaceutical use |
| 12/14/2005 | CN1231440C Novel tricyclic compound |
| 12/14/2005 | CN1231212C Multicyclic compounds which inhibit beukocyte adhesion mediated by VLA-4 |
| 12/13/2005 | US6974872 Process for production of piperidine derivatives |
| 12/13/2005 | US6974826 such as 3-(3,5,5,8,8-pentamethyl-5,6,7,8-tetrahydro-2-naphthyl)-4-methoxybenzylidene-2,4-thiazolidinedione; Hodgkin's disease |
| 12/08/2005 | US20050272787 Process for preparing crystalline form A of valdecoxib |
| 12/08/2005 | US20050272786 Naphthyl benzoxazoles and benzisoxazoles as estrogenic agents |
| 12/08/2005 | US20050272771 Such as terfenadine carboxylic acid metabolite and carebastine using a 4-(4-halo-1-oxobutyl)-alpha,alpha-dimethyl-alpha-substituted toluene intermediate |
| 12/08/2005 | US20050272745 Novel piperidine and piperazine derivatives |
| 12/08/2005 | US20050272718 Multicyclic compounds for use as melanin concentrating hormone antagonists in the treatment of obesity and diabetes |
| 12/07/2005 | EP1077928B1 Novel substituted cyclic compounds, preparation method and pharmaceutical compositions containing them |
| 12/07/2005 | EP1077927B1 Novel substituted cyclic compounds, preparation method and pharmaceutical compositions containing them |